News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Toby Eyre Shared NEJM Article on Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia
Toby Eyre/X
Jun 17, 2025, 09:52

Toby Eyre Shared NEJM Article on Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia

Toby Eyre, CLL specialist at the Oxford University Hospitals, shared a post on X:

“Big CLL news!
Munir et al
OS and PFS adv for MRD driven I and V over ibrutinib in 1L CLL EHA 2025.
Congrats to all FLAIR trial group.
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia, New England Journal of Medicine”

Title: Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia

Journal: NEJM

Authors: Talha Munir, Sean Girvan, David A. Cairns, Adrian Bloor, David Allsup, Abraham M. Varghese, Satyen Gohil, Shankara Paneesha, Andrew Pettitt, Toby Eyre, Christopher P. Fox, Francesco Forconi, Constantine Balotis, Nicholas Pemberton, Oonagh Sheehy, John Gribben, Nagah Elmusharaf, Simona Gatto, Gavin Preston, Anna Schuh, Renata Walewska, Lelia Duley, Nichola Webster, Surita Dalal, Andrew Rawstron, Dena Howard, Anna Hockaday, Sharon Jackson, Natasha Greatorex, Sue Bell, David Stones, Julia M. Brown, Piers E.M. Patten, Peter Hillmen

Read the full article.

Residual Disease-Guided Therapy

Read “25 Posts Not to Miss from EHA 2025“.

Residual Disease-Guided Therapy

Abraham M. Varghese Adrian Bloor Andrew Pettitt Andrew Rawstron Anna Hockaday Anna Schuh cancer Christopher P. Fox chronic lymphocytic leukemia CLL Constantine Balotis David A. Cairns David Allsup David Stones Dena Howard FLAIR FLAIR trial Francesco Forconi Gavin Preston ibrutinib John Gribben Julia M. Brown Lelia Duley Nagah Elmusharaf Natasha Greatorex NEJM Nichola Webster Nicholas Pemberton OncoDaily Oncology Oonagh Sheehy Oxford University Hospitals Peter Hillmen Piers E.M. Patten Renata Walewska Satyen Gohil Sean Girvan Shankara Paneesha Sharon Jackson Simona Gatto Sue Bell Surita Dalal Talha Munir Toby Eyre
Special Coverage
Blog
Jul 6, 2025, 19:46
How We Protect Progress - KidneyCAN
Blog
Jul 6, 2025, 19:33
ESGO 2026 Congress Will be Held in Copenhagen
Blog
Jul 6, 2025, 19:20
Haryana Dhillon: My 30th Year of Being a Member of the Clinical Oncology Society of Australia
Blog
Jul 6, 2025, 19:03
Join the TRANSiTION Programme, Adapt to the Latest Technologies for Better Oncology Care - European Cancer Organisation
Blog
Jul 6, 2025, 18:54
Steve Harvey: The Distribution of 68 Gene and RNA Therapies Approved Globally Might Surprise You
Blog
Jul 6, 2025, 18:44
Stephen V Liu: Register now for DC Lung 25
Blog
Jul 6, 2025, 18:17
Shubham Pant: Honored to Chair the KRAS in Pancreatic Cancer Symposium at ESMOGI
Celebrities
Jul 6, 2025, 18:11
Julian McMahon Dies at 56: A Look Back at His Private Cancer Battle and Legendary Acting Career
Blog
Jul 6, 2025, 18:01
Leonardo Gil-Santana: Our Real-World Data on PIK3CA-Mutated mCRC from Brazil at ESMOGI2025
Insight
Jul 6, 2025, 17:38
Hassan R. Hashmi: It’s Time to Treat Exercise as a Core Part of Cancer Care
Oncolibrary
Jul 6, 2025, 17:28
Climate Change and Cancer: Protecting Vulnerable Populations
Blog
Jul 6, 2025, 17:27
Florian Lordick: Novel Data and Future Challenges of Upper GI Cancers at ESMO GI 2025